PHARMAC

Pharmac is consulting on potential brand changes from the 2025/26 annual tender.

💬 Tell us how changing a brand of medicine might affect you and what support you'd need.

📝 Give us feedback on our online form:

Consultation on possible brand changes through the annual tender We are seeking feedback on possible brand changes for medicines in Pharmac’s annual tender.

📢 Funding confirmed for rare disorder treatment

Pharmac will fund nitisinone for people with tyrosinemia type 1 and alkaptonuria – two rare inherited metabolic disorders – from 1 February 2026.

This change will make it easier for clinicians to prescribe nitisinone and help ensure ongoing supply in New Zealand.

People currently receiving nitisinone through NPPA will continue treatment as usual but may need to change to the LogixX Pharma brand from February.

Find out more at:

Decision to fund nitisinone for people with rare inherited metabolic disorders Decision to fund nitisinone for people with rare inherited metabolic disorders 12 January 2026 Medicines Decision What we’re doing We are pleased to announce that nitisinone will be listed on the Pharmaceutical Schedule from 1 February 2026 for people with rare inherited metabolic disorders. This ...

📣 Have your say: Improving access to emergency medicines in rural communities

Getting fast emergency care can be especially challenging for people living in rural areas of New Zealand, where ambulances can take longer to arrive and hospitals may be further away.

Currently, some trauma and emergency services in the community don’t have the same access to funded medicines as Health NZ hospitals and ambulance services. This can affect people’s ability to get the medicines they need, when they need it.

Pharmac is proposing to extend funding of certain emergency medicines to other community services including PRIME services, and home birth services.

This would mean rural GPs, nurses, and midwives could access the same treatments for trauma and medical emergencies as hospitals and ambulances.

💬 We’re seeking feedback to make sure this change works for the people and services it affects.
📅 Consultation is open until Friday 19 December
📧 Email your feedback to: [email protected]
🔗 Learn more: https://www.pharmac.govt.nz/news-and-resources/news/pharmac-proposes-improved-access-to-emergency-medicines-in-rural-and-remote-communities